Simola N. Emerging drugs and targets for Parkinson’s disease. Cambridge: Royal Society of Chemistry 2014; pp. 61-82.
Youdim MBH, Fridkin M, Zheng H. Novel bifunctional drugs
targeting monoamine oxidase inhibition and iron chelation as an
approach to neuroprotection in Parkinson’s disease and other neurodegenerative
diseases. Basic neurosciences and genetics, Parkinson's
disease and allied conditions, Alzheimer's disease and related
disorders, biological psychiatry. 2004; 111: 1455-71
Rojas C, Rojas-Castaneda J, Ruiz-Sanchez E, Montes P, Rojas P. Antioxidant properties of a Ginkgo biloba leaf extract (EGb 761) in animal models of Alzheimer’s and Parkinson’s diseases. Curr Top Nutraceutical Res 2015; 13: 105.
Peng K, Tao Y, Zhang J, et al. Resveratrol regulates mitochondrial
biogenesis and fission/fusion to attenuate rotenone-induced neurotoxicity.
Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S.
Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum
of behavioral and psychological symptoms of dementia: metaanalysis
of randomized controlled trials. 2018; 285-93.
Boots AW, Haenen GRMM, Bast A. Health effects of quercetin:
From antioxidant to nutraceutical. 2008; 325-7.